Deutsche Bank Ag\ Sight Sciences, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 18,556 shares of SGHT stock, worth $69,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,556

Previous 9,927 86.92%

Holding current value

$69,213

Previous $66,000 75.76%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.49 - $8.31 $47,373 - $71,706	8,629 Added 86.92%	18,556 $116,000
Q2 2024 Aug 14, 2024	BUY	$5.13 - $7.15 $246 - $343	48 Added 0.49%	9,927 $66,000
Q1 2024 May 15, 2024	BUY	$4.02 - $5.89 $37,269 - $54,606	9,271 Added 1524.84%	9,879 $52,000
Q3 2023 Nov 09, 2023	SELL	$2.88 - $8.8 $44,046 - $134,587	-15,294 Reduced 96.18%	608 $2,000
Q2 2023 Aug 14, 2023	SELL	$7.46 - $10.67 $149,364 - $213,634	-20,022 Reduced 55.73%	15,902 $131,000
Q1 2023 May 15, 2023	BUY	$8.44 - $13.35 $37,937 - $60,008	4,495 Added 14.3%	35,924 $313,000
Q4 2022 Feb 13, 2023	BUY	$5.58 - $13.94 $792 - $1,979	142 Added 0.45%	31,429 $383,000
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $126,245 - $236,141	20,696 Added 195.41%	31,287 $198,000
Q2 2022 Aug 11, 2022	SELL	$6.61 - $11.99 $10,093 - $18,308	-1,527 Reduced 12.6%	10,591 $95,000
Q1 2022 May 13, 2022	BUY	$11.56 - $17.9 $61,383 - $95,048	5,310 Added 78.0%	12,118 $140,000
Q4 2021 Feb 11, 2022	SELL	$17.36 - $27.36 $5,329 - $8,399	-307 Reduced 4.31%	6,808 $120,000
Q3 2021 Nov 04, 2021	BUY	$22.34 - $39.1 $158,949 - $278,196	7,115 New	7,115 $162,000

Others Institutions Holding SGHT

# of Institutions

Shares Held

21.6M

Call Options Held

66.8K

Put Options Held

13K

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $178M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account